Subcutaneous administration of a monoclonal antibody to prevent malaria

K Kayentao, A Ongoiba, AC Preston… - … England Journal of …, 2024 - Mass Medical Soc
Background Subcutaneous administration of the monoclonal antibody L9LS protected adults
against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal …
被引用次数：9 相关文章

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.

K Kayentao, A Ongoiba, AC Preston… - The New England …, 2024 - europepmc.org
Background Subcutaneous administration of the monoclonal antibody L9LS protected adults
against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal …
[PDF] malariaworld.org

[PDF][PDF] Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

K Kayentao, A Ongoiba, AC Preston, SA Healy, Z Hu… - 2024 - media.malariaworld.org
BACKGROUND Subcutaneous administration of the monoclonal antibody L9LS protected
adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a …
[PDF] mpg.de

[PDF][PDF] Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

K Kayentao, A Ongoiba, AC Preston… - The New England …, 2024 - pure.mpg.de
BACKGROUND Subcutaneous administration of the monoclonal antibody L9LS protected
adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a …
[PDF] medicine-opera.com

[PDF][PDF] Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

K Kayentao, A Ongoiba, AC Preston, SA Healy… - N Engl J …, 2024 - medicine-opera.com
BACKGROUND Subcutaneous administration of the monoclonal antibody L9LS protected
adults against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a …

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

K Kayentao, A Ongoiba, AC Preston… - The New England …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Subcutaneous administration of the monoclonal antibody L9LS protected adults
against controlled Plasmodium falciparum infection in a phase 1 trial. Whether a monoclonal …

[引用][C] Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria

K Kayentao, A Ongoiba… - New England …, 2024 - Massachusetts Medical Society